Status: Recruiting
The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France
This post-market surveillance study is primarily designed to demonstrate the ongoing safety of the Control-IQ system, the ongoing performance of glycemic control and quality of life with Control-IQ system use, and the rate of use of the Control-IQ system. The system will be assessed in all approved populations during the first 12 months of use.
Participants needed: 350
Trial details
Age: 6+Biological sex: AllType: ObservationalSponsor: Tandem Diabetes Care, Inc.Updated: May 1, 2026Locations: 21
Eligibility criteria
Clinician-confirmed type 1 diabetes and for whom the site has initiated the t:sl... [+8]
A medical or other condition, or medications being taken that, in the investigat... [+1]